Shares of Quest Diagnostics (DGX) reached a new 52-week high on Tuesday after the diagnostic services provider exceeded ...

Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that the ...

Quest Diagnostics Incorporated DGX on Tuesday reported fourth-quarter adjusted earnings of $2.42 per share, beating the consensus of $2.36. The provider of diagnostic information services reported ...

Quest Diagnostics expects full-year earnings in the range of $10.50 to $10.70 per share, with revenue in the range of $11.7 ...

Shares of Quest Diagnostics rose after the company's full-year outlook and quarterly results topped Wall Street's expectations. The stock was up 4.9% to $200.53 in midday trading on Tuesday. Earlier ...

Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.35. Anticipation surrounds Quest Diagnostics's announcement, with investors hoping to hear about both surpassing ...

Quest Diagnostics' board has raised the company's quarterly dividend by 7.5%, to 86 cents from 80 cents, and added $1 billion to the diagnostic information services provider's stock-buyback program.

DGX heads into Q4 earnings with expected revenue and EPS growth, DIS momentum, and benefits from Fresenius assets and ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Quest Diagnostics on Tuesday forecast 2026 profit and revenue above Wall Street estimates after beating expectations for fourth-quarter results on strong demand for its diagnostic tests.

Quest Diagnostics Incorporated stock reached an all-time high of $198.00, marking a significant milestone for the company. With a market capitalization of $21.6 billion, the diagnostic testing leader ...

For fiscal year 2026, Quest Diagnostics expects revenue between $11.70 billion and $11.82 billion, above the analyst consensus of $11.36 billion. However, the company’s adjusted EPS guidance of $10.50 ...